SURROZEN INC (SRZN) — insider trading
Health Care · NASDAQ
SURROZEN INC (SRZN) has 23 reported SEC Form 4 insider transactions in our data, including 5 open-market sales among the most recent 23 (latest 2026-07-22).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | TCG Crossover GP II, LLC; TCG Crossover Fund II, L.P.; TCG Crossover GP III, LLC; TCG Crossover Fund III, L.P.; Yu Chen-Ming | 10% owner | Open-market sale | 162,500 | $21.25 | $3.45M | Form 4 |
| 2026-07-22 | TCG Crossover GP II, LLC; TCG Crossover Fund II, L.P.; TCG Crossover GP III, LLC; TCG Crossover Fund III, L.P.; Yu Chen-Ming | 10% owner | Open-market sale | 162,500 | $21.25 | $3.45M | Form 4 |
| 2026-06-15 | Parker Craig C | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 1,622 | $8.11 | $13.2K | Form 4 |
| 2026-06-15 | Williams Charles O | Officer (Chief Operating Officer) | Grant / award / vesting | 1,666 | $8.11 | $13.5K | Form 4 |
| 2026-06-15 | Li Yang | Officer (Exec. Vice President, Research) | Grant / award / vesting | 1,666 | $8.11 | $13.5K | Form 4 |
| 2026-06-15 | Maleki Andrew Pedrum | Officer (Chief Financial Officer) | Grant / award / vesting | 607 | $19.01 | $11.5K | Form 4 |
| 2026-05-13 | Kutzkey Tim | Director, 10% owner | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | Berkenblit Anna | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | BJERKHOLT ERIC | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | CHAI CHRISTOPHER Y | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | Haak-Frendscho Mary | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | WOODHOUSE DAVID J | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-13 | Rothenberg Mace | Director | Grant / award / vesting (derivative) | 5,550 | — | $0 | Form 4 |
| 2026-05-04 | Parker Craig C | Director, Officer (Chief Executive Officer) | Open-market sale | 4,524 | $33.33 | $150.8K | Form 4 |
| 2026-05-04 | Williams Charles O | Officer (Chief Operating Officer) | Open-market sale | 2,036 | $33.33 | $67.9K | Form 4 |
| 2026-05-04 | Li Yang | Officer (Exec. Vice President, Research) | Open-market sale | 1,584 | $33.33 | $52.8K | Form 4 |
| 2026-05-01 | Parker Craig C | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 12,500 | — | $0 | Form 4 |
| 2026-05-01 | Parker Craig C | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 12,500 | — | — | Form 4 |
| 2026-05-01 | Williams Charles O | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 5,625 | — | $0 | Form 4 |
| 2026-05-01 | Williams Charles O | Officer (Chief Operating Officer) | Option exercise / conversion | 5,625 | — | — | Form 4 |
| 2026-05-01 | Li Yang | Officer (Exec. Vice President, Research) | Option exercise / conversion (derivative) | 4,375 | — | $0 | Form 4 |
| 2026-05-01 | Li Yang | Officer (Exec. Vice President, Research) | Option exercise / conversion | 4,375 | — | — | Form 4 |
| 2026-03-31 | Li Yang | Officer (Exec. Vice President, Research) | Bona fide gift | 1,666 | — | $0 | Form 4 |
Ask the chat about SRZN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SURROZEN INC (SRZN).
Last updated 2026-07-22 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.